InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: davidal66 post# 379

Thursday, 06/30/2016 6:58:57 PM

Thursday, June 30, 2016 6:58:57 PM

Post# of 2099
We will find out soon what caused today's move, imo. Only catalyst in Q3 is the FDA meeting on phase 2 Ovarian. I don't think that was the cause of today's move because the data has been published. Perhaps the phase 2 went well and VB-111 received fast track designation for ovarian?

The company is also actively looking for partners for its NASH products so that can happen at any time.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News